The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.

The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.

Item
http://www.wikidata.org/entity/Q34458071
Use of Activated Recombinant Factor VII in Severe Bleeding - Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding.Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma.Influence of cardiopulmonary bypass on the interaction of recombinant factor VIIa with activated platelets.Pharmacological concentrations of recombinant factor VIIa restore hemostasis independent of tissue factor in antibody-induced hemophilia mice.Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven)Inhibitor development in haemophilia B: an orphan disease in need of attention.Hemostatic therapy for the treatment of intracranial hemorrhage.Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids.Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.The endothelial protein C receptor enhances hemostasis of FVIIa administration in hemophilic mice in vivo.Complementary effect of fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and combined use during three deliveries.Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd report.Predicting dosing advantages of factor VIIa variants with altered tissue factor-dependent and lipid-dependent activities.The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.Engineering of a membrane-triggered activity switch in coagulation factor VIIa.Citrate artificially masks the haemostatic effect of recombinant factor VIIa in dilutional coagulopathy.A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics.
P2860

The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.

Item
http://www.wikidata.org/entity/Q34458071
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
@ast
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
@en
The action of high-dose factor VIIa
@nl
type
label
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
@ast
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
@en
The action of high-dose factor VIIa
@nl
prefLabel
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
@ast
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
@en
The action of high-dose factor VIIa
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis
@en
P2093
P304
P31
P356
10.1016/S0037-1963(01)90140-4
P433
P478
P50
P577
P698